Embla Medical hf
CSE:EMBLA
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
26
36.3
|
Price Target |
|
We'll email you a reminder when the closing price reaches DKK.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one EMBLA stock under the Base Case scenario is 39.12 DKK. Compared to the current market price of 35.9 DKK, Embla Medical hf is Undervalued by 8%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Embla Medical hf
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for EMBLA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Embla Medical hf
Balance Sheet Decomposition
Embla Medical hf
Current Assets | 401.5m |
Cash & Short-Term Investments | 81.2m |
Receivables | 129.6m |
Other Current Assets | 190.7m |
Non-Current Assets | 1.2B |
Long-Term Investments | 27m |
PP&E | 200m |
Intangibles | 908.7m |
Other Non-Current Assets | 45.3m |
Current Liabilities | 201.6m |
Accounts Payable | 29.4m |
Accrued Liabilities | 46.7m |
Other Current Liabilities | 125.5m |
Non-Current Liabilities | 597.1m |
Long-Term Debt | 488.1m |
Other Non-Current Liabilities | 109m |
Earnings Waterfall
Embla Medical hf
Revenue
|
840.3m
USD
|
Cost of Revenue
|
-319.2m
USD
|
Gross Profit
|
521.1m
USD
|
Operating Expenses
|
-415.2m
USD
|
Operating Income
|
105.9m
USD
|
Other Expenses
|
-36.9m
USD
|
Net Income
|
69.1m
USD
|
Free Cash Flow Analysis
Embla Medical hf
USD | |
Free Cash Flow | USD |
EMBLA Profitability Score
Profitability Due Diligence
Embla Medical hf's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
Score
Embla Medical hf's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
EMBLA Solvency Score
Solvency Due Diligence
Embla Medical hf's solvency score is 56/100. The higher the solvency score, the more solvent the company is.
Score
Embla Medical hf's solvency score is 56/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
EMBLA Price Targets Summary
Embla Medical hf
According to Wall Street analysts, the average 1-year price target for EMBLA is 38.99 DKK with a low forecast of 33.33 DKK and a high forecast of 43.05 DKK.
Dividends
Current shareholder yield for EMBLA is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Össur hf is a global orthopaedics company, which engages in the design, development, manufacture, and sale of non-invasive orthopedic products. The firm is active in the development and distribution of products in the fields of non-invasive prosthetics, medical braces and supports. The firm's business activities are divided into three business segment: The Prosthetics, its product portfolio includes a range of lower and upper limb prosthetic components; The Bracing & Supports, which offers the Unloader One range of knee braces that relieve pain from knee osteoarthritis, as well as the Unloader Hip which is designed to reduce pain by optimizing load dispersion for patients suffering from mild and moderate osteoarthritis of the hip; and The Patient Care, which operates a network of Patient Care clinics around the world, with each one catering to individual patients and their needs.
Officers
The intrinsic value of one EMBLA stock under the Base Case scenario is 39.12 DKK.
Compared to the current market price of 35.9 DKK, Embla Medical hf is Undervalued by 8%.